The US Food and Drug Administration (FDA) has issued a draft guidance related to presentation of risk and benefit information for FDA-regulated prescription drugs and medical devices on electronic/digital platforms that are associated with character space limitations (e.g., Twitter, paid/sponsored links on internet search engines). …
Anzeige
Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten